Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 18, 2018 - Issue 11
Submit an article Journal homepage
1,739
Views
4
CrossRef citations to date
0
Altmetric
Review

Managing side effects in adjuvant endocrine therapy for breast cancer

Rosaria CondorelliDepartment of Medical Oncology, Gustave Roussy, Villejuif, France;Medical Oncology, Institute of Oncology and Breast Unit of Southern Switzerland, Bellinzona, SwitzerlandView further author information
&
Ines Vaz-LuisDepartment of Medical Oncology, Gustave Roussy, Villejuif, FranceCorrespondence[email protected]
View further author information
Pages 1101-1112 | Received 29 Oct 2017, Accepted 03 Sep 2018, Published online: 21 Sep 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Shaoqing Chen, Yifang Gao, Haichao Liu, Jin Jing, Zhengyu Yang, Haoming Zhu, Bairui Chen, Yu Wang, Ting Zhang, Shizhong Wang & Jianping Lin. (2023) Chinese medicinal herbs for reducing endocrine therapy-induced side effects in patients with hormone receptor‐positive breast cancer: a systematic review and meta-analysis. Pharmaceutical Biology 61:1, pages 722-736.
Read now
Zerko Wako, Daniel Mengistu, Negalign Getahun Dinegde, Tseganesh Asefa & Mulugeta Wassie. (2021) Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study. Breast Cancer: Targets and Therapy 13, pages 383-392.
Read now
Mia Fogh, Astrid Højgaard, Charlotte Birkmose Rotbøl & Anders Bonde Jensen. (2021) The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study. Acta Oncologica 60:1, pages 61-68.
Read now
Katherine R. Walter, Justin M. Balko & Christy R. Hagan. (2020) Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer. OncoImmunology 9:1.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.